MEDGENICS, INC.·4

Sep 17, 7:40 PM ET

MEDGENICS, INC. 4

4 · MEDGENICS, INC. · Filed Sep 17, 2013

Insider Transaction Report

Form 4
Period: 2013-09-13
Leaman John Harold
Chief Financial Officer
Transactions
  • Award

    Option Award (right to buy)

    2013-09-13+800,000800,000 total
    Exercise: $4.22Exp: 2023-09-13Common Stock (800,000 underlying)
Footnotes (1)
  • [F1]The option award vests over a three year period, with one-third of the options vesting on the first anniversary of the grant date and the balance vesting in equal increments on a monthly basis over the following two years.

Documents

1 file
  • 4
    v355233_4.xmlPrimary

    OWNERSHIP DOCUMENT